National Research Corp. engages in the provision of analytics and insights that facilitate patient, employee, and customer retention. The company is headquartered in Lincoln, Nebraska and currently employs 357 full-time employees. Its digital solutions consist of four solution categories: Patient Experience, Consumer Experience, Employee Experience, and Market Experience, which can be implemented both collectively as an enterprise solution or individually to meet specific needs within the organization. Its Marketing solutions are subscription-based services that allow for improved tracking of awareness, perception, and consistency of healthcare brands; real-time assessment of competitive differentiators, and enhanced segmentation tools. Its Reputation solutions allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs better consumer decision-making.
Based on comprehensive analyst evaluations, we have synthesized critical insights from expert assessments to outline a cautious outlook for NRC. Analysts note deteriorating fundamentals and challenging market sentiment, indicating potential downside risks in the near term. Following this expert analysis, we adopt a bearish stance on this stock. Our conclusion: NRC is a Sell candidate.
NRC stock price ended at $17.32 on 水曜日, after rising 2.00%
On the latest trading day Apr 01, 2026, the stock price of NRC rose by 2.00%, climbing from $17.23 to $17.32. Throughout the session, the stock experienced a volatility of 5.14%, with prices fluctuating between a daily low of $16.73 and a high of $17.59. Alongside this price increase, trading volume also rose by 6.0K shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 60.2K shares were traded, amounting to a market value of approximately $394.0M.